MedTrace Logo

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

NCT00733252 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-10-02

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as optical coherence tomography, may help find and diagnose lung cancer or precancerous cells.

PURPOSE: This phase I trial is studying how well optical coherence tomography of the airway works in detecting abnormal cells in patients undergoing surgery for lung cancer or lung disease.

Conditions

Interventions

PROCEDURE

bronchoscopic and lung imaging studies

Bronchoscopic imaging and optical coherence tomography are performed on lung tissue samples collected during surgery.

PROCEDURE

diagnostic bronchoscopy

Bronchoscopic imaging and optical coherence tomography are performed on lung tissue samples collected during surgery.

PROCEDURE

histopathologic examination

All imaged areas are marked. The marked areas are then excised and fixed in formalin for histopathologic analysis.

PROCEDURE

optical coherence tomography

Bronchoscopic imaging and optical coherence tomography are performed on lung tissue samples collected during surgery.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Rana Hejal, MD · Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2011-01-31
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00733252 on ClinicalTrials.gov